Research On The Economic Consequences Of The Directional Issuance Of Zhongheng Group

China's pharmaceutical industry is in a period of relatively rapid development.Both the industrial scale and the sales volume have maintained an average annual increase of about 10%.The huge profit growth space not only prompts the large-scale enterprises in the industry to accelerate the pace of expansion,but also constantly attracts other excellent enterprises and institutions at home and abroad to get involved in the field of medicine.They hope Strive for more medical resources and market share while improving their own market competitiveness.To achieve the above goals,pharmaceutical companies tend to be financed through the integration of ways,so how to scientifically financing has gradually become the focus of China's pharmaceutical companies.For listed companies,the main means of financing mainly include public offering,private placement,rights issue,convertible bonds.Among them,the private placement started in 2006,the overall size of the market has maintained a relatively steady momentum of development,and the total amount of financing in individual years also declined slightly.However,this steady growth trend has been broken since 2014,and the size of the private placement market in 2015 has doubled from 2014 and doubled from 2015 onwards.In 2016,China's private placement market raised 1.2646 trillion yuan in total.Thus,private placement has become the most widely used direct financing method in China's capital market.In addition,the financing status of the pharmaceutical industry in recent years,private placement is also the pharmaceutical industry listed companies the main financing.This article selects Zhongheng Group as a case,and uses a variety of research methods to analyze the private placement of listed pharmaceutical companies.First of all,it introduces the research background of private placement from the current market economy system,introduces the research significance,the research goal,the main research content,the research methods and the innovation points from the theoretical and practical significance.Secondly,the research results of domestic and foreign scholars Followed by the introduction of the characteristics of China's pharmaceutical industry,the status quo,and China's private placement market situation;then from the industry-leading position,raised a significant amount and for project financing,operating in good condition,elaborating the basis for the selection of cases,a brief The basic process of private placement of Zhongheng Group is summarized.The pricing and quantity of the issue of private placement of Zhongheng Group,the subscribers,the comparison of the shareholders before and after the private placement and the rationality of the proposal are introduced.Financial performance analysis;Finally,based on the previous analysis to summarize and give my own suggestions.